The Value of Histological Algorithms to Predict the Malignancy Potential of Pheochromocytomas and Abdominal Paragangliomas-A Meta-Analysis and Systematic Review of the Literature.
GAPP
PASS
histology
meta-analysis
paraganglioma
pheochromocytoma
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
15 Feb 2019
15 Feb 2019
Historique:
received:
21
01
2019
revised:
11
02
2019
accepted:
13
02
2019
entrez:
17
2
2019
pubmed:
17
2
2019
medline:
17
2
2019
Statut:
epublish
Résumé
Pheochromocytomas (PCCs) and abdominal paragangliomas (PGLs), collectively abbreviated PPGLs, are neuroendocrine tumors of the adrenal medulla and paraganglia, respectively. These tumors exhibit malignant potential but seldom display evidence of metastatic spread, the latter being the only widely accepted evidence of malignancy. To counter this, pre-defined histological algorithms have been suggested to stratify the risk of malignancy: Pheochromocytoma of the Adrenal Gland Scaled Score (PASS) and the Grading system for Adrenal Pheochromocytoma and Paraganglioma (GAPP). The PASS algorithm was originally intended for PCCs whereas the GAPP model is proposed for stratification of both PCCs and PGLs. In parallel, advances in terms of coupling overtly malignant PPGLs to the underlying molecular genetics have been made, but there is yet no combined risk stratification model based on histology and the overall mutational profile of the tumor. In this review, we systematically meta-analyzed previously reported cohorts using the PASS and GAPP algorithms and acknowledge a "rule-out" way of approaching these stratification models rather than a classical "rule-in" strategy. Moreover, the current genetic panorama regarding possible molecular adjunct markers for PPGL malignancy is reviewed. A combined histological and genetic approach will be needed to fully elucidate the malignant potential of these tumors.
Identifiants
pubmed: 30769931
pii: cancers11020225
doi: 10.3390/cancers11020225
pmc: PMC6406721
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Subventions
Organisme : Cancerfonden
ID : Junior Clinical Investigator Award
Organisme : Svenska Sällskapet för Medicinsk Forskning
ID : Stora Etableringsanslaget
Références
Eur J Cancer. 2000 Sep;36(14):1769-72
pubmed: 10974624
Am J Surg Pathol. 2002 May;26(5):551-66
pubmed: 11979086
Mod Pathol. 2004 Sep;17(9):1119-28
pubmed: 15167935
Endokrynol Pol. 2005 Nov-Dec;56(6):911-6
pubmed: 16821210
Urology. 2006 Aug;68(2):282-6
pubmed: 16904437
Physiol Res. 2008;57 Suppl 1:S171-9
pubmed: 18271679
Surgery. 2008 Jun;143(6):759-68
pubmed: 18549892
Am J Surg Pathol. 2009 Apr;33(4):599-608
pubmed: 19145205
Ann Surg. 2009 Apr;249(4):641-7
pubmed: 19300224
Horm Metab Res. 2009 Sep;41(9):715-9
pubmed: 19718615
World J Surg. 2010 Dec;34(12):3022-8
pubmed: 20703467
Endocrine. 2011 Apr;39(2):160-6
pubmed: 21069578
Urology. 2011 May;77(5):1155-60
pubmed: 21146858
Hum Mol Genet. 2011 Oct 15;20(20):3974-85
pubmed: 21784903
Langenbecks Arch Surg. 2012 Feb;397(2):239-46
pubmed: 22069042
Urology. 2012 Sep;80(3):736.e7-12
pubmed: 22698476
Pol J Pathol. 2012 Dec;63(4):235-42
pubmed: 23359192
Prilozi. 2012;33(2):23-40
pubmed: 23425867
Tunis Med. 2013 Mar;91(3):209-15
pubmed: 23588637
Pol J Pathol. 2013 Jun;64(2):129-35
pubmed: 23900871
Nat Rev Cancer. 2014 Feb;14(2):108-19
pubmed: 24442145
Endocr Relat Cancer. 2014 May 06;21(3):405-14
pubmed: 24521857
Asian Pac J Cancer Prev. 2014;15(4):1751-5
pubmed: 24641403
Endocr Relat Cancer. 2014 May 06;21(3):427-34
pubmed: 24803525
BMC Surg. 2015 Aug 28;15:101
pubmed: 26314582
Endocr Pathol. 2016 Sep;27(3):243-52
pubmed: 27262318
J Clin Diagn Res. 2016 Sep;10(9):EC01-EC04
pubmed: 27790441
Rom J Morphol Embryol. 2016;57(2 Suppl):651-661
pubmed: 27833956
Intern Med. 2016;55(24):3611-3621
pubmed: 27980262
PLoS One. 2016 Dec 16;11(12):e0168413
pubmed: 27992508
Neuroendocrinology. 2017;105(4):384-393
pubmed: 28122379
Cancer Cell. 2017 Feb 13;31(2):181-193
pubmed: 28162975
Langenbecks Arch Surg. 2017 Aug;402(5):787-798
pubmed: 28229225
Endocr Pract. 2017 Jun;23(6):690-704
pubmed: 28332883
Endocr Rev. 2017 Dec 1;38(6):489-515
pubmed: 28938417
Endocr Relat Cancer. 2018 Jan;25(1):1-9
pubmed: 28974544
PLoS One. 2017 Nov 8;12(11):e0187398
pubmed: 29117221
Surg Endosc. 2018 Jul;32(7):3401
pubmed: 29218662
Hormones (Athens). 2017 Oct;16(4):388-395
pubmed: 29518759
Langenbecks Arch Surg. 2018 Sep;403(6):785-790
pubmed: 29779047
Int J Surg Case Rep. 2018;50:111-115
pubmed: 30099264
Endocr Pathol. 2018 Dec;29(4):302-309
pubmed: 30155766
Clin Cancer Res. 2019 Jan 15;25(2):760-770
pubmed: 30301828
Case Rep Endocrinol. 2018 Oct 14;2018:6358485
pubmed: 30405919
Am J Surg Pathol. 2019 Mar;43(3):409-421
pubmed: 30451732